Researchers at the University of Michigan have found a new
potential benefit of a molecule in green tea: preventing the misfolding of
specific proteins in the brain.
The aggregation of these proteins, called metal-associated
amyloids, is associated with Alzheimer's disease and other neurodegenerative
conditions.
A paper published recently in the Proceedings of the
National Academy of Sciences explained how Life Sciences Institute faculty
member Mi Hee Lim and an interdisciplinary team of researchers used green tea
extract to control the generation of metal-associated amyloid-β aggregates
associated with Alzheimer's disease in the lab.